A phase 3, randomized, double-blind, placebo-controlled, multi-center study to investigate the efficacy and safety of eliglustat in patients with Gaucher disease type 1 (ENGAGE): Results after 9 months of treatment

Mistry, Pramod K; Lukina, Elena; Ben, Dridi Marie-Francoise; Amato, Dominick J; Baris, Hagit; Dasouki, Majed; Ghosn, Marwan; Mehta, Atul; Packman, Seymour; Pastores, Gregory M; Petakov, Milan S; Peterschmitt, Judith M

Results

eNauka > Results > A phase 3, randomized, double-blind, placebo-controlled, multi-center study to investigate the efficacy and safety of eliglustat in patients with Gaucher disease type 1 (ENGAGE): Results after 9 months of treatment

Title:	A phase 3, randomized, double-blind, placebo-controlled, multi-center study to investigate the efficacy and safety of eliglustat in patients with Gaucher disease type 1 (ENGAGE): Results after 9 months of treatment
Authors:	Mistry, Pramod K; Lukina, Elena; Ben, Dridi Marie-Francoise; Amato, Dominick J; Baris, Hagit; Dasouki, Majed; Ghosn, Marwan; Mehta, Atul; Packman, Seymour; Pastores, Gregory M; Petakov, Milan S; Peterschmitt, Judith M;
Issue Date:	2013
Publication:	MOLECULAR GENETICS AND METABOLISM
ISSN:	1096-7192 Molecular Genetics and Metabolism Search Idenfier
Type:	Conference Paper
Collation:	vol. 108 br. 2 str. S66-S67
DOI:	10.1016/j.ymgme.2012.11.171
WoS-ID:	000314670500159
URI:	https://enauka.gov.rs/handle/123456789/825819
Metadata source:	(Preuzeto iz Nasi u WoS)
M-category:	Mp. category will be shown later

1
OpenCitations

1
WEB OF SCIENCE^TM

Altmetric

Dimensions

Find the DOI

Finding a DOI in CrossRef based on publication meta-data. The DOI (and metadata) with the similar data match will be displayed. ATTENTION - it doesn't have to be that publication.

Unpaywall

Google Scholar^TM